ZYBT logo

ZHENGYE BIOTECHNOLOGY-A

ZYBTNASDAQ
๐Ÿ† #4929 by market capUS Equity
$1.53โ–ฒ $0.03 (+1.67%)
Market closed ยท at close
๐Ÿ””
Track ZYBT
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ฒ 1.7%
7dโ–ฒ 1.7%
14dโ–ฒ 1.7%
30dโ–ผ 0.3%
ytdโ–ฒ 32.6%
1yโ–ผ 30.7%
๐ŸฆMarket Cap
$45M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-4.2%
Declining
๐Ÿ“ŠGross Margin
24.2%
Moderate
๐Ÿ’ตFCF Margin
8.6%
Moderate
โš–๏ธP/S Ratio
1.5x
Cheap
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$1.52 โ€“ $1.52
52-Week Range
โ€”
Volume (shares)
100
Avg Volume (shares)
โ€”
Shares Outstanding
29.7M
Next Earnings
โ€”

Fundamentals Snapshot

Annual Revenue
โ€”
Last Q Revenue
โ€”
P/E Ratio
โ€”
P/S Ratio
1.5x
EPS (TTM)
โ€”
Dividend Yield
0.00%
ZYBT logo

ZHENGYE BIOTECHNOLOGY-A

ZYBT
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About ZHENGYE BIOTECHNOLOGY-A

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.